{"count": 2, "results": [{"_id": "35847929", "pmid": 35847929, "pmcid": "PMC9283643", "title": "Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab", "journal": "Front Oncol", "authors": ["Ren T", "Jia H", "Wu Q", "Zhang Y", "Ma Q", "Yao D", "Gao X", "Xie D", "Xu Z", "Zhao Q", "Zhang Y"], "date": "2022-07-01T00:00:00Z", "doi": "10.3389/fonc.2022.829059", "meta_date_publication": "2022", "meta_volume": "12", "meta_issue": "", "meta_pages": "829059", "score": 50251.71, "text_hl": "Then, an experiment in @CELLLINE_CVCL:0291 @@@HCT116@@@ @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@colon cancer@@@ cell xenografts in @SPECIES_10090 @@@mice@@@ was explored to confirm the combined treatment with @CHEMICAL_Bevacizumab @CHEMICAL_MESH:D000068258 @@@Bev@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lis@@@), a RASI, could inhibit angiogenesis and ECM remodeling.", "citations": {"NLM": "Ren T, Jia H, Wu Q, Zhang Y, Ma Q, Yao D, Gao X, Xie D, Xu Z, Zhao Q, Zhang Y. Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab Front Oncol. 2022;12():829059. PMID: 35847929", "BibTeX": "@article{35847929, title={Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab}, author={Ren T and Jia H and Wu Q and Zhang Y and Ma Q and Yao D and Gao X and Xie D and Xu Z and Zhao Q and Zhang Y}, journal={Front Oncol}, volume={12}, pages={829059}}"}}, {"_id": "20697294", "pmid": 20697294, "title": "Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps.", "journal": "J Clin Gastroenterol", "authors": ["Kedika R", "Patel M", "Pena Sahdala HN", "Mahgoub A", "Cipher D", "Siddiqui AA"], "date": "2011-02-01T00:00:00Z", "doi": "10.1097/MCG.0b013e3181ea1044", "meta_date_publication": "2011 Feb", "meta_volume": "45", "meta_issue": "2", "meta_pages": "e12-6", "score": 50054.23, "text_hl": "BACKGROUND: The long-term use of angiotensin converting enzyme (ACE) inhibitors may reduce the risk of developing @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@colorectal cancer@@@ (@<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@CRC@@@). ", "citations": {"NLM": "Kedika R, Patel M, Pena Sahdala HN, Mahgoub A, Cipher D, Siddiqui AA. Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps. J Clin Gastroenterol. 2011 Feb;45(2):e12-6. PMID: 20697294", "BibTeX": "@article{20697294, title={Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps.}, author={Kedika R and Patel M and Pena Sahdala HN and Mahgoub A and Cipher D and Siddiqui AA}, journal={J Clin Gastroenterol}, volume={45}, number={2}, pages={e12-6}}"}}]}